A study to test how well BI 3720931 is tolerated and whether it improves lung function in people with cystic fibrosis (LenticlairTM 1)
ongoing trials trial from other registries
Details- 2023
SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes - Phase 2|Phase 3 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2023
- Amir Moheet|University of Minnesota
A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis - Phase 1|Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2023
- Clarametyx Biosciences, Inc.
A Phase 3, Open-label, and Rollover Study to Evaluate the Long-term Safety and Tolerability of Lumacaftor/Ivacaftor Treatment in Subjects With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation
ongoing trials trial from other registries
Details- 2023
A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairaflyâ¢) - Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2023
- Boehringer Ingelheim
Estrogen Patches for Adolescent and Young Adult Women With Cystic Fibrosis - Phase 4 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2023
- Johns Hopkins University|Cystic Fibrosis Foundation
Evaluation of the effects of curcumin-piperine in reducing Pseudomonas infection and improving clinical outcome in patients with cystic fibrosis - Pending
ongoing trials trial from other registries
Details- 2023
Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations - Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- Aceragen
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study - Phase 4 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- Chris Goss|University of Washington|Medical University of South Carolina|Cystic Fibrosis Foundation|Seattle Children's Hospital
A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa - Phase 1|Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- National Institute of Allergy and Infectious Diseases (NIAID)